Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 SCHOTT Pharma Opens New Production Facility for Prefillable Glass Syringes in Hungary | Contract Pharma

What are you searching for?

Sign in
Breaking News

SCHOTT Pharma Opens New Production Facility for Prefillable Glass Syringes in Hungary

Expands its global capacities for strategically important high-value solutions that address key pharma trends.

Author Image

By: Charlie Sternberg

Associate Editor, Contract Pharma

SCHOTT Pharma has opened a new production facility for high-quality prefillable glass syringes in Hungary.
 
Supported by a EUR 9 million ($9.7 billion) investment from the local government, SCHOTT Pharma is expanding its global capacities for strategically important high-value solutions that address key pharma trends. At the same time, the company is strengthening its competitiveness in Europe and the supply security for major pharmaceutical companies and contract manufacturing organizations.
 
To supply the fast and dynamically growing market, SCHOTT Pharma plans to further invest a multi-million Euro amount in Hungary in prefillable syringes in the near future.
 
“With an increasing number of drugs being stored in prefillable glass syringes – from GLP-1 drugs to critical vaccines and innovative biologics, the manufacturing beginning at this site today will continue to support major trends in the pharma industry,” says Andreas Reisse, CEO of SCHOTT Pharma.
 
As evidenced by their growing demand in the healthcare industry, these high-quality prefillable glass syringes not only offer a stable, long-term storage solution for drugs, but also a safe and convenient delivery system for patients and clinicians.
 
SCHOTT Pharma’s Hungarian site, which was inaugurated in Lukácsháza today, builds on the company’s existing foundation and pharmaceutical production skillset in the area, which already plays an important role in supplying the global industry with drug containment systems today.
 
The facility is equipped with state-of-the-art machinery and is the second site where the company manufactures glass syringes, in addition to the site in St. Gallen, Switzerland.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics